Detalhe da pesquisa
1.
Jagged2 targeting in lung cancer activates anti-tumor immunity via Notch-induced functional reprogramming of tumor-associated macrophages.
Immunity
; 57(5): 1124-1140.e9, 2024 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38636522
2.
Patient reported outcomes and patient experiences of immune checkpoint modulators for advanced or recurrent melanoma: a mixed methods study.
Support Care Cancer
; 32(6): 330, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38709312
3.
Circulating tumor DNA-based molecular residual disease detection for treatment monitoring in advanced melanoma patients.
Cancer
; 129(11): 1723-1734, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36869646
4.
Systematic evaluation of the predictive gene expression signatures of immune checkpoint inhibitors in metastatic melanoma.
Mol Carcinog
; 62(1): 77-89, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35781709
5.
Neoadjuvant Therapy in Melanoma: Where Are We Now?
Curr Oncol Rep
; 25(4): 325-339, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36781621
6.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36029412
7.
A Tumor and Immune-Related Micro-RNA Signature Predicts Relapse-Free Survival of Melanoma Patients Treated with Ipilimumab.
Int J Mol Sci
; 24(9)2023 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37175874
8.
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
J Transl Med
; 20(1): 253, 2022 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35659704
9.
Surveillance of Sentinel Node-Positive Melanoma Patients Who Receive Adjuvant Therapy Without Undergoing Completion Lymph Node Dissection.
Ann Surg Oncol
; 28(12): 6978-6985, 2021 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-34363118
10.
Risk tolerance in adjuvant and metastatic melanoma settings: a patient perspective study using the threshold technique.
Future Oncol
; 17(17): 2151-2167, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33709791
11.
Immunotherapy of cancer in 2012.
CA Cancer J Clin
; 62(5): 309-35, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22576456
12.
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Cancer
; 124(22): 4332-4341, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30303516
13.
Long term impact of CTLA4 blockade immunotherapy on regulatory and effector immune responses in patients with melanoma.
J Transl Med
; 16(1): 184, 2018 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29973204
14.
Using Genomic Sequencing to Improve Management in Melanoma.
Oncology (Williston Park)
; 32(3): 98-101, 104, 2018 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29548064
15.
Phase 1/2 study of rilotumumab (AMG 102), a hepatocyte growth factor inhibitor, and erlotinib in patients with advanced non-small cell lung cancer.
Cancer
; 123(15): 2936-2944, 2017 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28472537
16.
A phase 2 trial of dasatinib in patients with locally advanced or stage IV mucosal, acral, or vulvovaginal melanoma: A trial of the ECOG-ACRIN Cancer Research Group (E2607).
Cancer
; 123(14): 2688-2697, 2017 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28334439
17.
Melanoma antigen-specific effector T cell cytokine secretion patterns in patients treated with ipilimumab.
J Transl Med
; 15(1): 39, 2017 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28222797
18.
Adjuvant Therapy for Melanoma.
Curr Oncol Rep
; 19(5): 36, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28417343
19.
Update on adjuvant therapy in late-stage resected melanoma.
Clin Adv Hematol Oncol
; 19(12): 753-755, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34928928
20.
The current state of adjuvant therapy of melanoma.
Lancet Oncol
; 21(11): 1394-1395, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32961120